Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a220f6a41e86d937

Jump to content

// Workers AI · dad joke modeWhat did Octamoxin say? "I'm an antibiotic, I'm resistant to jokes.

From Wikipedia, the free encyclopedia

Octamoxin
Skeletal formula of octamoxin
Skeletal formula of octamoxin
Names
Preferred IUPAC name
1-Methylheptylhydrazine[citation needed]
Systematic IUPAC name
Octan-2-ylhydrazine[1]
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C8H20N2/c1-3-4-5-6-7-8(2)10-9/h8,10H,3-7,9H2,1-2H3 checkY
    Key: FODQIVGFADUBKE-UHFFFAOYSA-N checkY
  • CCCCCCC(C)NN
Properties
C8H20N2
Molar mass 144.262 g·mol−1
Density 0.831 g/mL
Boiling point 228 °C (442 °F; 501 K)
Pharmacology
Oral
Related compounds
Related compounds
Tuaminoheptane
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Octamoxin (trade names Ximaol, Nimaol), also known as 2-octylhydrazine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class that was used as an antidepressant in the 1960s but is now no longer marketed.[2][3][4][5]

See also

[edit]

References

[edit]
  1. "Octamoxin - Compound Summary". USA: National Center for Biotechnology Information. 26 March 2005. Identification and Related Records. Retrieved 31 May 2012.
  2. Ganellin CR, Triggle DJ (21 November 1996). Dictionary of pharmacological agents - Google Books. CRC Press. ISBN 9780412466304.
  3. "13-06781. Octamoxin [Archived]: The Merck Index".
  4. Levy J, Michel-Ber E (1966). "[Relations between the antidepressive effects of octamoxine revealed by 3 pharmacological tests and inhibition of cerebral monoamine oxidase in mice]". Thérapie (in French). 21 (4): 929–45. PMID 5925088.
  5. Gayral L, Stern H, Puyuelo R (1966). "[Indications and results of the treatment of mental depression by octamoxine (ximaol)]". Thérapie (in French). 21 (5): 1183–90. PMID 5976767.